Fresenius Medical Care (FME.DE) Akcie Kurz
Fresenius Medical Care Kurz
Tržby rostly o 6,0 % ročně za posledních 19 let na 19,63 Mld. EUR. Zisk na akcii rostl o 4,9 % ročně za posledních 19 let. čistá marže společnosti Fresenius Medical Care je nyní 5,0 %, převážně stabilní z 5,5 % před několika lety. Fresenius Medical Care aktuálně nabízí dividendový výnos kolem 3,56 %. Výplatní poměr je kolem 42 % zisku. Dividenda rostla o 6,8 % ročně za posledních 19 let. Medián cílové ceny analytiků je 46,92 EUR, tedy nad aktuální cenu o 16,1 %. Z 27 analytiků jich 11 doporučuje nákup — celkový konsenzus je Držet.
Cena akcie Fresenius Medical Care
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Fresenius Medical Care a analýza akcií
Nejčastější otázky týkající se akcie Fresenius Medical Care
Fresenius Medical Care AG is a leading global provider of dialysis products, services, and solutions for patients with chronic kidney failure. The company's business model revolves around providing high-quality dialysis care to patients in over 120 countries. Fresenius Medical Care AG offers a comprehensive range of dialysis machines, dialyzers, and other related products to ensure efficient and effective treatment. Furthermore, the company operates a network of dialysis clinics, providing personalized care for patients worldwide. With a focus on innovation, research, and development, Fresenius Medical Care AG continuously strives to enhance patient outcomes and improve the overall quality of life for individuals with kidney disease.
Fresenius Medical Care AG is primarily active in the healthcare industry.
The main competitors of Fresenius Medical Care AG in the market are DaVita Inc., Baxter International Inc., and B. Braun Melsungen AG.
Fresenius Medical Care AG is a leading global healthcare company specializing in dialysis products and services. Established in 1996, it stemmed from the merger of Fresenius AG and National Medical Care. With its headquarters in Germany, the company has expanded its reach worldwide, operating in nearly 150 countries. Fresenius Medical Care AG is renowned for its expertise in renal therapy, offering innovative dialysis machines, dialyzers, and related medical supplies. As a market leader, it provides life-saving treatments to millions of people suffering from chronic kidney disease. The company's commitment to delivering high-quality care and advancing renal healthcare has made Fresenius Medical Care AG a trusted name in the medical industry.
Fresenius Medical Care AG, a leading healthcare company, has achieved significant milestones throughout its history. It pioneered the development of advanced dialysis products and services, revolutionizing the treatment of end-stage renal disease. The company has established a global presence, operating in over 120 countries and serving millions of patients worldwide. Additionally, Fresenius Medical Care AG has continuously expanded its business through strategic acquisitions and collaborations, strengthening its position as a market leader in dialysis care. With a commitment to research and development, the company has achieved breakthrough innovations in dialysis technology, enhancing patient outcomes and quality of life. Overall, Fresenius Medical Care AG’s impressive achievements have solidified its reputation as a trusted provider of renal therapies.
Fresenius Medical Care AG is primarily present in various countries and regions across the globe. With a strong global presence, the company operates in more than 150 countries and regions, including the United States, Germany, Asia-Pacific, Latin America, and Europe. Its widespread international network enables Fresenius Medical Care AG to provide advanced renal care products, services, and solutions to patients worldwide. As the global leader in dialysis and kidney care, Fresenius Medical Care AG continues to expand its reach and impact, ensuring quality healthcare for patients globally.
Fresenius Medical Care AG represents values of quality, innovation, and patient-centered care. With a dedicated corporate philosophy, the company focuses on providing life-saving dialysis products, therapies, and services to patients worldwide. The commitment to excellence, compassion, and continuous advancement in medical technology enables Fresenius Medical Care AG to enhance patients' quality of life and deliver optimal renal care. As a global leader in the field, Fresenius Medical Care AG maintains a strong emphasis on scientific research, sustainability, and delivering efficient healthcare solutions for patients suffering from chronic kidney diseases.
Analytici aktuálně stanovují průměrnou cílovou cenu 45,79 EUR pro akcii Fresenius Medical Care (medián: 46,92 EUR), tedy +13,3 % vůči poslední ceně. Konsensus vychází z 27 hodnocení analytiků.
27 analytiků aktuálně hodnotí akcii Fresenius Medical Care: 11 doporučuje koupit, 9 držet a 7 prodat. Pro rok 2026 analytici očekávají u Fresenius Medical Care tržby 19,45 Mld. EUR a zisk na akcii 4,18 EUR.
Akcie Fresenius Medical Care (FME.DE) je kótována na 10 burzách, mimo jiné: London (0H9X.L), SIX (Zürich) (FMEEUR.SW), XETRA (FME.DE), Frankfurt (FME.F), München (FME.MU), Düsseldorf (FME.DU), Hamburg (FME.HM), Wien (FME.VI).
Fresenius Medical Care AG is a leading provider of products and services for the dialysis treatment of patients with kidney failure. The company is headquartered in Bad Homburg, Germany, and operates in over 120 countries worldwide. Fresenius Medical Care also operates its own dialysis centers and offers various other medical services. The business model of Fresenius Medical Care includes three business segments: dialysis products, services related to dialysis treatment, and the care of patients with chronic diseases. In the field of dialysis products, Fresenius Medical Care develops and produces a wide range of dialysis equipment and reagents. These products are sold to both their own dialysis centers and other medical facilities worldwide. Thanks to technological innovations in dialysis treatment, medical professionals can offer patients better outcomes and a higher quality of life. In the second business segment, Fresenius Medical Care provides services related to dialysis treatment. The company operates and manages its own dialysis centers and also provides the necessary medical professionals. Additionally, Fresenius Medical Care offers technical support and training for the use of their own dialysis products. These services are an important part of the business model as they ensure both the sales of their own products and the high-quality medical care of patients. A third business segment of Fresenius Medical Care is the care of patients with chronic diseases. Through the use of data analysis and telemedicine technologies, medical professionals from Fresenius Medical Care can actively care for patients - both online and through home visits. The goal is to improve the health of patients and avoid hospital stays. The business model of Fresenius Medical Care is based on preventive health care and support for people with chronic diseases such as kidney failure. By providing high-quality products and services and establishing a comprehensive patient care program, Fresenius Medical Care strengthens its position as a leading provider in dialysis treatment. In recent years, Fresenius Medical Care has also increased its investment in research and development of innovative treatment methods to continuously improve the quality of medical care for patients with chronic diseases. The extensive expertise in this field enables the development of new treatment modalities, including digital solutions, that benefit patients. Overall, Fresenius Medical Care is an innovative company specializing in the provision of products and services for dialysis treatment. By combining technological innovations, a comprehensive patient care program, and a constant focus on the needs of medical professionals in the global healthcare industry, the company relies on a forward-looking, promising business model in a sector of growing importance.
Tržby očekávané za Fresenius Medical Care činí 19,45 Mld. EUR. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk očekávané za Fresenius Medical Care činí 1,20 Mld. EUR. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Fresenius Medical Care je aktuálně 9,66. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Fresenius Medical Care.
Poměr ceny k tržbám (P/S) Fresenius Medical Care je aktuálně 0,59. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Fresenius Medical Care.
Score kvality pro Fresenius Medical Care je 2/10.
ISIN Fresenius Medical Care je DE0005785802. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Fresenius Medical Care je 578580. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Fresenius Medical Care je FME.DE. Symbol tickeru se používá k obchodování akcií Fresenius Medical Care na burze.
Fresenius Medical Care akcie
Fresenius Medical Care Peer Group
Fresenius Medical Care Ticker
Fresenius Medical Care FIGI
Všechny fundamentální údaje o Fresenius Medical Care v podrobné analýze
Naše analýzy akcií společnosti Fresenius Medical Care zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Fresenius Medical Care. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: